Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice
Guidelines for diagnosis, treatment and follow-up

J 2021

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

BOSSI, P.; A. T. CHAN; L. LICITRA; A. TRAMA; E. ORLANDI et. al.

Základní údaje

Originální název

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Autoři

BOSSI, P. (garant); A. T. CHAN; L. LICITRA; A. TRAMA; E. ORLANDI; E. P. HUI; Jana HALÁMKOVÁ (203 Česká republika, domácí); S. MATTHEIS; B. BAUJAT; J. HARDILLO; L. SMEELE; C. VAN HERPEN; A. CASTRO a J. P. MACHIELS

Vydání

Annals of Oncology, AMSTERDAM, Oxford University Press, 2021, 0923-7534

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 51.769

Kód RIV

RIV/00216224:14110/21:00122115

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.annonc.2020.12.007

UT WoS

000629502100007

EID Scopus

2-s2.0-85100683380

Klíčová slova anglicky

nasopharyngeal cancer; Clinical Practice Guidelines; diagnosis; treatment; follow-up

Štítky

14110811, Excelence Science, MOÚ, RIV, rivok, user

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 17. 3. 2022 12:40, Mgr. Tereza Miškechová

Anotace

V originále

This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided. Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.

Návaznosti

LM2018128, projekt VaV

Název: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)

Citovat

BOSSI, P.; A. T. CHAN; L. LICITRA; A. TRAMA; E. ORLANDI; E. P. HUI; Jana HALÁMKOVÁ; S. MATTHEIS; B. BAUJAT; J. HARDILLO; L. SMEELE; C. VAN HERPEN; A. CASTRO a J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. AMSTERDAM: Oxford University Press, 2021, roč. 32, č. 4, s. 452-465. ISSN 0923-7534. Dostupné z: https://dx.doi.org/10.1016/j.annonc.2020.12.007.

@article{1786779,
   author = {Bossi, P. and Chan, A. T. and Licitra, L. and Trama, A. and Orlandi, E. and Hui, E. P. and Halámková, Jana and Mattheis, S. and Baujat, B. and Hardillo, J. and Smeele, L. and van Herpen, C. and Castro, A. and Machiels, J. P.},
   article_location = {AMSTERDAM},
   article_number = {4},
   doi = {http://dx.doi.org/10.1016/j.annonc.2020.12.007},
   keywords = {nasopharyngeal cancer; Clinical Practice Guidelines; diagnosis; treatment; follow-up},
   language = {eng},
   issn = {0923-7534},
   journal = {Annals of Oncology},
   title = {Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up},
   url = {https://www.sciencedirect.com/science/article/pii/S0923753420432107?via%3Dihub},
   volume = {32},
   year = {2021}
}

TY  - JOUR
ID  - 1786779
AU  - Bossi, P. - Chan, A. T. - Licitra, L. - Trama, A. - Orlandi, E. - Hui, E. P. - Halámková, Jana - Mattheis, S. - Baujat, B. - Hardillo, J. - Smeele, L. - van Herpen, C. - Castro, A. - Machiels, J. P.
PY  - 2021
TI  - Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
JF  - Annals of Oncology
VL  - 32
IS  - 4
SP  - 452-465
EP  - 452-465
PB  - Oxford University Press
SN  - 09237534
KW  - nasopharyngeal cancer
KW  - Clinical Practice Guidelines
KW  - diagnosis
KW  - treatment
KW  - follow-up
UR  - https://www.sciencedirect.com/science/article/pii/S0923753420432107?via%3Dihub
N2  - This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided. Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.
ER  -

BOSSI, P.; A. T. CHAN; L. LICITRA; A. TRAMA; E. ORLANDI; E. P. HUI; Jana HALÁMKOVÁ; S. MATTHEIS; B. BAUJAT; J. HARDILLO; L. SMEELE; C. VAN HERPEN; A. CASTRO a J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. \textit{Annals of Oncology}. AMSTERDAM: Oxford University Press, 2021, roč.~32, č.~4, s.~452-465. ISSN~0923-7534. Dostupné z: https://dx.doi.org/10.1016/j.annonc.2020.12.007.

Přehled o publikaci